[SLRX] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
05-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 70.86%
YoY- 71.73%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 165 105 163 251 246 179 283 -30.27%
PBT -1,385 -2,230 -2,009 -2,638 -9,052 -8,223 -8,029 -69.11%
Tax 0 0 -51 0 0 0 -74 -
NP -1,385 -2,230 -2,009 -2,638 -9,052 -8,223 -8,029 -69.11%
Tax Rate - - - - - - - -
Total Cost 1,549 2,335 2,172 2,889 9,297 8,402 8,312 -67.47%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -840.76 -2,124.68 -1,232.52 -1,051.18 -3,687.09 -4,604.73 -2,837.10 -55.64%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -11.48 -77.16 -69.50 -91.27 -313.66 -287.22 -284.43 -88.30%
EPS Diluted -11.48 -77.16 -69.50 -91.27 -313.66 -287.22 -284.43 -88.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.